Actively Recruiting
Heart Failure-USB: Prediction and Progression
Led by University Hospital, Basel, Switzerland · Updated on 2025-04-10
6000
Participants Needed
1
Research Sites
394 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and/ or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.
CONDITIONS
Official Title
Heart Failure-USB: Prediction and Progression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients hospitalized with a primary diagnosis of ACS
- Patients hospitalized with a primary or secondary diagnosis of AHF
You will not qualify if you...
- Existence of a documented statement of the patient against the scientific use of clinical data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cardiology, University Hospital Basel
Basel, Switzerland, 4031
Actively Recruiting
Research Team
C
Christian Müller, Prof. Dr.
CONTACT
F
Fiona Nafaa, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here